Rob Janssen

Track

Insider profile

Currently holds a position at Dynavax Technologies Corp

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer, Senior Vice President - Clinical Development, Medical and Regulatory Affairs Dynavax Technologies Corp Jan. 1, 2018 -
Chief Medical Officer, Vice President - Clinical Development and Regulatory Affairs Dynavax Technologies Corp July 9, 2013 - Jan. 1, 2018
Rob Janssen's trades of Dynavax Technologies Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-08 2024-01-04
PlS Planned sale
84,231 -48.1%
227.34
US$3,658,061 		84,231 -48.1% 227.34 US$3,658,061
2024-01-04 2024-01-04
PrS Proposed sale
67,813
32.47
US$585,163 		67,813 32.47 US$585,163
2023-10-11 2023-10-10
PlS Planned sale
21,909 +36.8%
380.24
US$2,988,417 		21,909 +36.8% 380.24 US$2,988,417
2023-10-03 2023-10-02
PlS Planned sale
5,015 -9.1%
15.03
US$75,375 		5,015 -9.1% 15.03 US$75,375
2023-08-25 2023-08-24
PlS Planned sale
600 -1.2%
15.02
US$9,012 		600 -1.2% 15.02 US$9,012
2023-08-24 2023-08-23
PlS Planned sale
34,857 -41.1%
15.01
US$523,204 		34,857 -41.1% 15.01 US$523,204
2023-08-09 2023-08-08
PlS Planned sale
2,600 -5.0%
15.05
US$39,130 		2,600 -5.0% 15.05 US$39,130
2023-08-08 2023-08-08
PrS Proposed sale
113,250
14.89
US$1,686,292 		113,250 14.89 US$1,686,292
2022-08-10 2022-08-09
S Sale
7,938 -18.3%
16.92
US$134,277 		7,938 -18.3% 16.92 US$134,277
2022-08-09 2022-08-08
PlS Planned sale
4,450 -15.3%
17.16
US$76,365 		4,450 -15.3% 17.16 US$76,365
2022-08-09 2022-08-05
PlS Planned sale
900 -3.5%
17.01
US$15,311 		900 -3.5% 17.01 US$15,311
2022-03-04 2022-03-03
S Sale
17,760 -41.8%
10.57
US$187,723 		17,760 -41.8% 10.57 US$187,723
2022-03-04 2022-03-03
S Sale
6,276 -12.9%
10.56
US$66,275 		6,276 -12.9% 10.56 US$66,275
2021-11-18 2021-11-17
S Sale
53,431 -86.6%
17.07
US$912,292 		53,431 -86.6% 17.07 US$912,292
2021-11-18 2021-11-16
S Sale
35,974 -81.3%
17.16
US$617,479 		35,974 -81.3% 17.16 US$617,479
2021-08-10 2021-08-06
PlS Planned sale
80,000 -92.1%
10.75
US$860,000 		80,000 -92.1% 10.75 US$860,000
2021-02-03 2021-02-01
PlS Planned sale
42,155 -32.8%
10.64
US$448,529 		42,155 -32.8% 10.64 US$448,529
2020-07-20 2020-07-17
PlS Planned sale
50,000 -28.2%
11.09
US$554,500 		50,000 -28.2% 11.09 US$554,500
2020-05-19 2020-05-19
PlS Planned sale
15,000 -7.8%
6.33
US$94,950 		15,000 -7.8% 6.33 US$94,950
2020-05-07 2020-05-06
PlS Planned sale
28,000 -12.7%
4.52
US$126,560 		28,000 -12.7% 4.52 US$126,560
2020-05-07 2020-05-05
PlS Planned sale
9,000 -3.9%
4.43
US$39,870 		9,000 -3.9% 4.43 US$39,870